Diabetes, Vol 46, Issue 6 1010-1016, Copyright © 1997 by American Diabetes Association

ARTICLES

Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM

G Perriello, S Pampanelli, P Del Sindaco, C Lalli, M Ciofetta, E Volpi, F Santeusanio, P Brunetti and GB Bolli
Dipartimento di Medicina Interna e Scienze Endocrine e Metaboliche, Universita di Perugia, Italy.

To assess the mechanisms of fasting hyperglycemia in NIDDM patients with mild elevation of fasting plasma glucose (FPG) compared with NIDDM patients with overt hyperglycemia, we studied 29 patients with NIDDM, who were divided in two groups according to their fasting plasma glucose (<7.8 and > or =7.8 mmol/l for groups A and B, respectively), and 16 control subjects who were matched with NIDDM patients for age, sex, and body mass index. All subjects were infused with [3-3H]glucose between 10:00 P.M. and 10:00 A.M. during overnight fasting to determine glucose fluxes. In 27 subjects (17 diabetic and 10 control), [U-14C]alanine was simultaneously infused between 4:00 A.M. and 10:00 A.M. to measure gluconeogenesis (GNG) from alanine. Arterialized-venous plasma samples were collected every 30 min for measurement of glucose fluxes, GNG, and glucoregulatory hormones. In group A, plasma glucose, rate of systemic glucose production (SGP), and GNG were greater than in control subjects (7.2 +/- 0.2 vs. 4.9 +/- 0.1 mmol/l, 10.9 +/- 0.2 vs. 9.5 +/- 0.3 micromol x kg(-1) x min(-1), and 0.58 +/- 0.04 vs. 0.37 +/- 0.02 micromol x kg(-1) x min(-1), respectively, for group A and control subjects; mean value 8:00 A.M.-10:00 A.M., all P < 0.05). Both increased SGP and GNG correlated with plasma glucose in all subjects (r = 0.77 and r = 0.75, respectively, P < 0.005). Plasma counterregulatory hormones did not differ in NIDDM patients compared to control subjects. The present studies demonstrate that SGP and GNG are increased in NIDDM patients without overt fasting hyperglycemia. Thus these metabolic abnormalities primarily contribute to early development of overnight and fasting hyperglycemia in NIDDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Bock, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, V. Chandramouli, B. R. Landau, and R. A. Rizza Contribution of Hepatic and Extrahepatic Insulin Resistance to the Pathogenesis of Impaired Fasting Glucose: Role of Increased Rates of Gluconeogenesis Diabetes, June 1, 2007; 56(6): 1703 - 1711. [Abstract] [Full Text] [PDF]

				P. D. van Poelje, S. C. Potter, V. C. Chandramouli, B. R. Landau, Q. Dang, and M. D. Erion Inhibition of Fructose 1,6-Bisphosphatase Reduces Excessive Endogenous Glucose Production and Attenuates Hyperglycemia in Zucker Diabetic Fatty Rats Diabetes, June 1, 2006; 55(6): 1747 - 1754. [Abstract] [Full Text] [PDF]

				B. J. Lamont, S. Visinoni, B. C. Fam, M. Kebede, B. Weinrich, S. Papapostolou, H. Massinet, J. Proietto, J. Favaloro, and S. Andrikopoulos Expression of Human Fructose-1,6-Bisphosphatase in the Liver of Transgenic Mice Results in Increased Glycerol Gluconeogenesis Endocrinology, June 1, 2006; 147(6): 2764 - 2772. [Abstract] [Full Text] [PDF]

				R. Basu, V. Chandramouli, B. Dicke, B. Landau, and R. Rizza Obesity and Type 2 Diabetes Impair Insulin-Induced Suppression of Glycogenolysis as Well as Gluconeogenesis Diabetes, July 1, 2005; 54(7): 1942 - 1948. [Abstract] [Full Text] [PDF]

				M. D. Erion, P. D. van Poelje, Q. Dang, S. R. Kasibhatla, S. C. Potter, M. R. Reddy, K. R. Reddy, T. Jiang, and W. N. Lipscomb MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes PNAS, May 31, 2005; 102(22): 7970 - 7975. [Abstract] [Full Text] [PDF]

				A. Gastaldelli, Y. Miyazaki, M. Pettiti, E. Buzzigoli, S. Mahankali, E. Ferrannini, and R. A. DeFronzo Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3914 - 3921. [Abstract] [Full Text] [PDF]

				R. Basu, W. F. Schwenk, and R. A. Rizza Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62. [Abstract] [Full Text] [PDF]

				I. E. Peterside, M. A. Selak, and R. A. Simmons Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1258 - E1266. [Abstract] [Full Text] [PDF]

				R. H. Lane, N. K. MacLennan, J. L. Hsu, S. M. Janke, and T. D. Pham Increased Hepatic Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator-1 Gene Expression in a Rat Model of Intrauterine Growth Retardation and Subsequent Insulin Resistance Endocrinology, July 1, 2002; 143(7): 2486 - 2490. [Abstract] [Full Text] [PDF]

				P. Staehr, O. Hother-Nielsen, K. Levin, J. J. Holst, and H. Beck-Nielsen Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients Diabetes, June 1, 2001; 50(6): 1363 - 1370. [Abstract] [Full Text]

				G. Boden, X. Chen, and T. P. Stein Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E23 - E30. [Abstract] [Full Text] [PDF]

				S. Matthaei, M. Stumvoll, M. Kellerer, and H.-U. Häring Pathophysiology and Pharmacological Treatment of Insulin Resistance Endocr. Rev., December 1, 2000; 21(6): 585 - 618. [Abstract] [Full Text]

				A. Balasubramanyam, S. McKay, P. Nadkarni, A. S. Rajan, A. Garza, V. Pavlik, J. A. Herd, F. Jahoor, and P. J. Reeds Ethnicity affects the postprandial regulation of glycogenolysis Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E905 - E914. [Abstract] [Full Text] [PDF]

				F. Diraison, V. Large, C. Maugeais, M. Krempf, and M. Beylot Noninvasive tracing of human liver metabolism: comparison of phenylacetate and apoB-100 to sample glutamine Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E529 - E536. [Abstract] [Full Text] [PDF]

				F. Saker, J. Ybarra, P. Leahy, R. W. Hanson, S. C. Kalhan, and F. Ismail-Beigi Glycemia-lowering effect of cobalt chloride in the diabetic rat: role of decreased gluconeogenesis Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E984 - E991. [Abstract] [Full Text] [PDF]